According to the UK SmPC (Summary of Product Characteristics), gastrointestinal symptoms are common, with nausea occurring in up to 20% of patients, diarrhoea in approximately 12%, and vomiting in around 9%
Novo Nordisk has two products containing semaglutide
Remember to discuss the dosage and other instructions with your healthcare provider
Each option provides a safe, effective path to long-term success under medical supervision
4 Discussion Our systematic review and meta-analysis aimed to explore how Semaglutide compares to three other GLP-1 receptor agonists (GLP-1 RAs): Dulaglutide, Liraglutide, and Tirzepatide
2-10 Users $300 Annually per user $300/year Get Started $300 Annually per user To submit a correction request, please visit our Contact Us page.